What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Heart failure
His primary areas of investigation include Internal medicine, Cardiology, Cardiomyopathy, Hypertrophic cardiomyopathy and Heart disease.
His Internal medicine research includes themes of Gene mutation and Pathology.
His Cardiomyopathy research includes elements of Placebo, Fabry disease and Clinical significance.
His research in Hypertrophic cardiomyopathy intersects with topics in Left ventricular hypertrophy, Fibrosis, Myocardial fibrosis, Magnetic resonance imaging and Muscle hypertrophy.
His Heart disease study incorporates themes from Mitral valve, Physical exercise and Diastole.
His Transplantation research integrates issues from Heart failure with preserved ejection fraction and Cardiac contractility modulation.
His most cited work include:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (3307 citations)
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) (2051 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Heart failure.
His study in Internal medicine concentrates on Sudden death, Sudden cardiac death, Left ventricular hypertrophy, Dilated cardiomyopathy and Heart disease.
While the research belongs to areas of Cardiology, he spends his time largely on the problem of Disease, intersecting his research to questions surrounding Intensive care medicine.
His study in Hypertrophic cardiomyopathy is interdisciplinary in nature, drawing from both Muscle hypertrophy, Surgery, Gene mutation and Pathology.
His Cardiomyopathy research is multidisciplinary, incorporating perspectives in Phenotype and Electrocardiography.
His biological study focuses on Ejection fraction.
He most often published in these fields:
- Internal medicine (69.38%)
- Cardiology (59.56%)
- Hypertrophic cardiomyopathy (50.52%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (69.38%)
- Cardiomyopathy (28.42%)
- Cardiology (59.56%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cardiomyopathy, Cardiology, Hypertrophic cardiomyopathy and Sudden cardiac death.
In his articles, Perry M. Elliott combines various disciplines, including Internal medicine and In patient.
His study looks at the intersection of Cardiomyopathy and topics like Disease with Intensive care medicine.
His Cardiology study integrates concerns from other disciplines, such as Randomized controlled trial and Cardiac magnetic resonance imaging.
His Hypertrophic cardiomyopathy research is multidisciplinary, relying on both Proband, Left ventricular hypertrophy, Gene mutation, Atrial fibrillation and Penetrance.
His studies deal with areas such as Implantable cardioverter-defibrillator, Ventricular tachycardia, Desmoplakin and Heart transplantation as well as Sudden cardiac death.
Between 2018 and 2021, his most popular works were:
- Germline selection shapes human mitochondrial DNA diversity. (73 citations)
- Germline selection shapes human mitochondrial DNA diversity. (73 citations)
- Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis (69 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His primary scientific interests are in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Sudden cardiac death.
His work on Right ventricular cardiomyopathy, Dilated cardiomyopathy and Infarction is typically connected to In patient as part of general Cardiology study, connecting several disciplines of science.
The concepts of his Hypertrophic cardiomyopathy study are interwoven with issues in Interquartile range, Gene mutation, Clinical screening, Penetrance and Cohort.
His Cardiomyopathy research is classified as research in Heart failure.
The concepts of his Heart failure study are interwoven with issues in Bioinformatics, Genetic testing and Amyloidosis.
He combines subjects such as Implantable cardioverter-defibrillator, Ventricular tachycardia, Subclinical infection and Desmoplakin with his study of Sudden cardiac death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
